IM-54 3/15/01 MEDICAID AND RICKY RAY HEMOPHILIA RELIEF FUND FH MR#9
| SUBJECT: |
| MEDICAID AND RICKY RAY HEMOPHILIA RELIEF
FUND
MANUAL REVISION: FAMILY HEALTHCARE #9 SECTION 905.010.45.55 |
| DISCUSSION: |
| The Ricky Ray Hemophilia Relief Fund was
established by the U.S. Congress in 1998 to make payments of $100,000 to
individuals with blood clotting disorders, who were treated with blood
plasma products between July 1, 1982 and December 31, 1987, and contracted
HIV. Certain spouses and children who contracted HIV from these individuals,
or their specified survivors may also receive payment. Settlement
payments may be made from the Ricky Ray Hemophilia Relief Fund, or paid
as a result of a class action settlement in the case of Susan Walker v.
Bayer Corporation.
These payments are not to be considered income or resources in determining eligibility for the federally funded Medicaid/MC+ Programs. Any money derived from the investment of these funds may be considered income. Thus, if the payments are placed in an interest-bearing account, or some other investment medium that produces income, the income generated by the account may be counted as income to the individual. Individuals receiving settlement payments who dispose of part or all of awarded moneys in a manner that normally would be considered a transfer of property, are excluded from any transfer penalties related to these funds. Similarly, settlement payments that may be placed in trusts, which would normally be governed by the trust provisions, are also excluded. However, any income derived from the trust may be considered income to the individual. |
| NECESSARY ACTION: |
Distribution #2 |